Publications of John S. March

Journal Articles

  1. March, J (1995). Anxiety Disorders in Children and Adolescents. Obsessive-compulsive disorder: a review of the past ten years. (in press).
  2. JS March, K Mulle and B Herbel (1994). Behavioral psychotherapy for children and adolescents with obsessive-compulsive disorder: an open trial of a new protocol-driven treatment package.. J Am Acad Child Adolesc Psychiatry, 33(3), 333-341.
  3. JS March and K Mulle (1995). Manualized cognitive-behavioral psychotherapy for obsessive-compulsive disorder in childhood: A preliminary single case study. Journal of Anxiety Disorders, 9(2), 175-184.
  4. JS March, HL Leonard and SE Swedo (1995). Pharmacotherapy of obsessive-compulsive disorder. Child and Adolescent Psychiatric Clinics of North America. Child Psychiatric Clinics of North America: Pharmacotherapy, 4(1), 217-236.
  5. JS March, L Amaya-Jackson, R Terry and P Costanzo (1997). Posttraumatic symptomatology in children and adolescents after an industrial fire.. J Am Acad Child Adolesc Psychiatry, 36(8), 1080-1088. (in press).
  6. JS March, JD Parker, K Sullivan, P Stallings and CK Conners (1997). The Multidimensional Anxiety Scale for Children (MASC): factor structure, reliability, and validity.. J Am Acad Child Adolesc Psychiatry, 36(4), 554-565. (in press).
  7. March, J. (1993). What Constitutes a Stressor? The "Criterion A" Issue. Posttraumatic Stress Disorder: DSM-IV and Beyond, 37-54.

Papers Published

  1. PS Jensen, LE Arnold, JM Swanson, B Vitiello, HB Abikoff, LL Greenhill, L Hechtman, SP Hinshaw, WE Pelham, KC Wells, CK Conners, GR Elliott, JN Epstein, B Hoza, JS March, BS Molina, JH Newcorn, JB Severe, T Wigal, RD Gibbons and K Hur (2007). 3-year follow-up of the NIMH MTA study.. J Am Acad Child Adolesc Psychiatry, 46(8), 989-1002.
  2. CJ Kratochvil, BS Vaughan, JA Stoner, JM Daughton, BD Lubberstedt, DW Murray, AK Chrisman, MA Faircloth, NB Itchon-Ramos, SH Kollins, LA Maayan, LL Greenhill, LA Kotler, J Fried and JS March (2011). A double-blind, placebo-controlled study of atomoxetine in young children with ADHD.. Pediatrics, 127(4), e862-e868.
  3. JS March, KA Kobak, JW Jefferson, J Mazza and JH Greist (1990). A double-blind, placebo-controlled trial of fluvoxamine versus imipramine in outpatients with major depression. Journal of Clinical Psychiatry, 51(5), 200-202.
  4. DE May, CJ Kratochvil, SE Puumala, SG Silva, AJ Rezac, MJ Hallin, MA Reinecke, B Vitiello, EB Weller, S Pathak, AD Simons and JS March (2007). A manual-based intervention to address clinical crises and retain patients in the Treatment of Adolescents With Depression Study (TADS).. J Am Acad Child Adolesc Psychiatry, 46(5), 573-581.
  5. CJ Kratochvil, A Simons, B Vitiello, J Walkup, G Emslie, D Rosenberg and JS March (2005). A multisite psychotherapy and medication trial for depressed adolescents: Background and benefits. Cognitive and Behavioral Practice, 12(2), 159-165.
  6. CJ Kratochvil, BS Vaughan, ML Mayfield-Jorgensen, JS March, SH Kollins, DW Murray, H Ravi, LL Greenhill, LA Kotler, N Paykina, P Biggins and J Stoner (2007). A pilot study of atomoxetine in young children with attention-deficit/hyperactivity disorder.. J Child Adolesc Psychopharmacol, 17(2), 175-185.
  7. RS Beidas, O Lindhiem, DM Brodman, A Swan, M Carper, C Cummings, PC Kendall, AM Albano, M Rynn, J Piacentini and E al (2013). A Probabilistic and Individualized Approach for Predicting Treatment Gains: An Extension and Application to Anxiety Disordered Youth. Behavior Therapy.
  8. JS March, AR Entusah, M Rynn, AM Albano and KA Tourian (2007). A Randomized controlled trial of venlafaxine ER versus placebo in pediatric social anxiety disorder.. Biol Psychiatry, 62(10), 1149-1154.
  9. J March, C Kratochvil, G Clarke, W Beardslee, A Derivan, G Emslie, EP Green, J Heiligenstein, S Hinshaw, K Hoagwood, P Jensen, P Lavori, H Leonard, J McNulty, MA Michaels, A Mossholder, T Osher, T Petti, E Prentice, B Vitiello and K Wells (2004). AACAP 2002 research forum: placebo and alternatives to placebo in randomized controlled trials in pediatric psychopharmacology.. J Am Acad Child Adolesc Psychiatry, 43(8), 1046-1056.
  10. JS March, P Szatmari, O Bukstein, A Chrisman, D Kondo, JD Hamilton, CM Kremer and CJ Kratochvil (2007). AACAP 2005 Research Forum: speeding the adoption of evidence-based practice in pediatric psychiatry.. J Am Acad Child Adolesc Psychiatry, 46(9), 1098-1110.
  11. TE Wilens, J Biederman, JS March, R Wolkow, CS Fine, RB Millstein, SV Faraone, D Geller and TJ Spencer (1999). Absence of cardiovascular adverse effects of sertraline in children and adolescents. Journal of the American Academy of Child and Adolescent Psychiatry, 38(5), 573-577.
  12. P Rohde, SG Silva, ST Tonev, BD Kennard, B Vitiello, CJ Kratochvil, MA Reinecke, JF Curry, AD Simons and JS March (2008). Achievement and maintenance of sustained response during the Treatment for Adolescents With Depression Study continuation and maintenance therapy.. Arch Gen Psychiatry, 65(4), 447-455.
  13. JS March (2003). Acute stress disorder in youth: a multivariate prediction model.. Biol Psychiatry, 53(9), 809-816.
  14. C Kratochvil, G Emslie, S Silva, S McNulty, J Walkup, J Curry, M Reinecke, B Vitiello, P Rohde, N Feeny, C Casat, S Pathak, E Weller, D May, T Mayes, M Robins and J March (2006). Acute time to response in the Treatment for Adolescents with Depression Study (TADS). Journal of the American Academy of Child and Adolescent Psychiatry, 45(12), 1412-1418.
  15. Adams, G. B., Waas, G. A., March, J. S., & Smith, M. C. (1994). Obsessive compulsive disorder in children and adolescents: The role of the school psychologist in identification, assessment, and treatment. School Psychology Quarterly, 9(4), 274-294..
  16. PS Jensen, SP Hinshaw, HC Kraemer, N Lenora, JH Newcorn, HB Abikoff, JS March, LE Arnold, DP Cantwell and E al (2001). ADHD comorbidity findings from the MTA study: Comparing comorbid subgroups. Journal of the American Academy of Child and Adolescent Psychiatry, 40(2), 147-158.
  17. D Antonuccio, D Burns, A Rifkin, W Rifkin, BJ Carroll, JA Bridge, DA Brent and JS March (2004). Adolescents with depression [1] (multiple letters). Journal of the American Medical Association, 292(21), 2577-2579.
  18. JS March and B Vitiello (2001). Advances in paediatric neuropsychopharmacology: an overview.. Int J Neuropsychopharmacol, 4(2), 141-147.
  19. SH Kollins and JS March (2007). Advances in the pharmacotherapy of attention-deficit/hyperactivity disorder.. Biol Psychiatry, 62(9), 951-953.
  20. Amaya-Jackson L, March J: Post-traumatic stress disorder in children and adolescents. In (ed Leonard H): Anxiety Disorders. Philadelphia, Sanders, 1993..
  21. Amaya-Jackson, L. (1995). Post-traumatic stress disorder in adolescents. Adolescent Medicine, 6(2), 251-270..
  22. Amaya-Jackson, L., & March, J. (1995). Posttraumatic stress disorder. In J. March (Ed.), Anxiety Disorders in Children and Adolescents (pp. 276-300). New York: Guilford..
  23. CH Avery, J March and RH Brook (1980). An assessment of the adequacy of self-care by adult asthmatics. Journal of Community Health, 5(3), 167-180.
  24. LD Miller, A Laye-Gindhu, JL Bennett, Y Liu, S Gold, JS March, BF Olson and VE Waechtler (2011). An effectiveness study of a culturally enriched school-based CBT anxiety prevention program.. J Clin Child Adolesc Psychol, 40(4), 618-629.
  25. DG Kondo, AK Chrisman and JS March (2003). An evidence-based medicine approach to combined treatment for ADHD in children and adolescents.. Psychopharmacol Bull, 37(3), 7-23.
  26. NC Feeny, SG Silva, MA Reinecke, S McNulty, RL Findling, P Rohde, JF Curry, GS Ginsburg, CJ Kratochvil, SM Pathak, DE May, BD Kennard, AD Simons, KC Wells, M Robins, D Rosenberg and JS March (2009). An exploratory analysis of the impact of family functioning on treatment for depression in adolescents.. J Clin Child Adolesc Psychol, 38(6), 814-825.
  27. A Prakash, E Lobo, CJ Kratochvil, RN Tamura, BA Pangallo, KE Bullok, T Quinlan, GJ Emslie and JS March (2012). An open-label safety and pharmacokinetics study of duloxetine in pediatric patients with major depression.. J Child Adolesc Psychopharmacol, 22(1), 48-55.
  28. JS March, JM Swanson, LE Arnold, B Hoza, CK Conners, SP Hinshaw, L Hechtman, HC Kraemer, LL Greenhill, HB Abikoff, LG Elliott, PS Jensen, JH Newcorn, B Vitiello, J Severe, KC Wells and WE Pelham (2000). Anxiety as a predictor and outcome variable in the multimodal treatment study of children with ADHD (MTA).. J Abnorm Child Psychol, 28(6), 527-541.
  29. MA Riddle, GA Bernstein, EH Cook, HL Leonard, JS March and JM Swanson (1999). Anxiolytics, adrenergic agents, and naltrexone. Journal of the American Academy of Child and Adolescent Psychiatry, 38(5), 546-556.
  30. DA Cole, S-J Cho, NC Martin, EA Youngstrom, JS March, RL Findling, BE Compas, IM Goodyer, P Rohde, M Weissman, MJ Essex, JS Hyde, JF Curry, R Forehand, MJ Slattery, JW Felton and MA Maxwell (2012). Are Increased Weight and Appetite Useful Indicators of Depression in Children and Adolescents?. JOURNAL OF ABNORMAL PSYCHOLOGY, 121(4), 838-851.
  31. C Wei, A Hoff, MA Villabø, J Peterman, PC Kendall, J Piacentini, J McCracken, JT Walkup, AM Albano, M Rynn and E al (2013). Assessing Anxiety in Youth with the Multidimensional Anxiety Scale for Children. Journal of Clinical Child and Adolescent Psychology.
  32. JN Epstein, CK Conners, AS Hervey, ST Tonev, LE Arnold, HB Abikoff, G Elliott, LL Greenhill, L Hechtman, K Hoagwood, SP Hinshaw, B Hoza, PS Jensen, JS March, JH Newcorn, WE Pelham, JB Severe, JM Swanson, K Wells, B Vitiello, T Wigal and MTA Cooperative Study Group (2006). Assessing medication effects in the MTA study using neuropsychological outcomes.. J Child Psychol Psychiatry, 47(5), 446-456.
  33. J Swanson, M Lerner, J March and FM Gresham (1999). Assessment and intervention for attention-deficit/hyperactivity disorder in the schools: Lessons from the MTA study. Pediatric Clinics of North America, 46(5), 993-1009.
  34. LL Greenhill, D Pine, J March, B Birmaher and M Riddle (1998). Assessment issues in treatment research of pediatric anxiety disorders: What is working, what is not working, what is missing, and what needs improvement. Psychopharmacology Bulletin, 34(2), 155-164.
  35. BD Kennard, SG Silva, TL Mayes, P Rohde, JL Hughes, B Vitiello, CJ Kratochvil, JF Curry, GJ Emslie, MA Reinecke, JS March and TADS (2009). Assessment of safety and long-term outcomes of initial treatment with placebo in TADS.. Am J Psychiatry, 166(3), 337-344.
  36. JN Epstein, CK Conners, D Erhardt, JS March and JM Swanson (1997). Asymmetrical hemispheric control of visual-spatial attention in adults with attention deficit hyperactivity disorder.. Neuropsychology, 11(4), 467-473.
  37. JS March (2010). Attention bias modification training and the new interventions research.. Biol Psychiatry, 68(11), 978-979.
  38. AK Roy, RA Vasa, M Bruck, K Mogg, BP Bradley, M Sweeney, RL Bergman, EB McClure-Tone, DS Pine, JT Walkup and E al (2008). Attention bias toward threat in pediatric anxiety disorders. Journal of the American Academy of Child and Adolescent Psychiatry, 47(10), 1189-1196.
  39. JS March, K Wells and CK Conners (1996). Attention-deficit/hyperactivity disorder: Part II. Treatment strategies. Journal of Practical Psychiatry and Behavioral Health, 2(1), 23-32.
  40. JS March (2005). Authors of TADS study reply to letter raising concerns [2]. British Medical Journal, 330(7493), 730-731.
  41. P Barrett, L Healy and JS March (2003). Behavioral avoidance test for childhood obsessive-compulsive disorder: A home-based observation. American Journal of Psychotherapy, 57(1), 80-100.
  42. JS March and B Vitiello (2009). Benefits exceed risks of newer antidepressant medications in youth--maybe.. Clin Pharmacol Ther, 86(4), 355-357.
  43. CP Keeton, GS Ginsburg, KL Drake, D Sakolsky, PC Kendall, B Birmaher, AM Albano, JS March, M Rynn, J Piacentini and E al (2013). Benefits Of Child-Focused Anxiety Treatments For Parents And Family Functioning. Depression and Anxiety.
  44. J March (1999). CBT plus parental anxiety management was more effective when the child and parent(s) were anxious: Commentary. Evidence-Based Mental Health, 2(3), 76-.
  45. H Chabrol, DA Brent, J Curry, SN Compton and JS March (2005). CBT versus supportive therapy for depression [1] (multiple letters). Journal of the American Academy of Child and Adolescent Psychiatry, 44(9), 841-843.
  46. J DeVeaugh-Geiss, J March, M Shapiro, PJ Andreason, G Emslie, LM Ford, L Greenhill, D Murphy, E Prentice, R Roberts, S Silva, JM Swanson, B van Zwieten-Boot, B Vitiello, KD Wagner and B Mangum (2006). Child and adolescent psychopharmacology in the new millennium: a workshop for academia, industry, and government.. J Am Acad Child Adolesc Psychiatry, 45(3), 261-270.
  47. SN Compton, JT Walkup, AM Albano, JC Piacentini, B Birmaher, JT Sherrill, GS Ginsburg, MA Rynn, JT McCracken, BD Waslick, S Iyengar, PC Kendall and JS March (2010). Child/Adolescent Anxiety Multimodal Study (CAMS): rationale, design, and methods.. Child Adolesc Psychiatry Ment Health, 4, 1.
  48. PC Kendall, SN Compton, JT Walkup, B Birmaher, AM Albano, J Sherrill, G Ginsburg, M Rynn, J McCracken, E Gosch and E al (2010). Clinical characteristics of anxiety disordered youth. Journal of Anxiety Disorders, 24(3), 360-365.
  49. JS March and B Vitiello (2009). Clinical messages from the Treatment for Adolescents With Depression Study (TADS).. Am J Psychiatry, 166(10), 1118-1123.
  50. P Szatmari and JS March (2007). Clinical practice guidelines.. J Am Acad Child Adolesc Psychiatry, 46(8), 939-940.
  51. JM Swanson, HC Kraemer, SP Hinshaw, LE Arnold, CK Conners, HB Abikoff, W Clevenger, M Davies, GR Elliott, LL Greenhill and E al (2001). Clinical relevance of the primary findings of the MTA: Success rates based on severity of ADHD and ODD symptoms at the end of treatment. Journal of the American Academy of Child and Adolescent Psychiatry, 40(2), 168-179.
  52. JH Greist, JW Jefferson, R Rosenfeld, LD Gutzmann, JS March and NE Barklage (1990). Clomipramine and obsessive compulsive disorder: A placebo-controlled double-blind study of 32 patients. Journal of Clinical Psychiatry, 51(7), 292-297.
  53. R Frost, G Steketee, N Amir, M Bouvard, C Carmin, DA Clark, J Cottraux, J Eisen, P Emmelkamp, E Foa and E al (1997). Cognitive assessment of obsessive-compulsive disorder. Behaviour Research and Therapy, 35(7), 667-681.
  54. ME Franklin, J Sapyta, JB Freeman, M Khanna, S Compton, D Almirall, P Moore, M Choate-Summers, A Garcia, AL Edson, EB Foa and JS March (2011). Cognitive behavior therapy augmentation of pharmacotherapy in pediatric obsessive-compulsive disorder: the Pediatric OCD Treatment Study II (POTS II) randomized controlled trial.. JAMA, 306(11), 1224-1232.
  55. ME Franklin, JB Freeman and JS March (2012). Cognitive behavior therapy for pediatric obsessive-compulsive disorder - Reply. JAMA - Journal of the American Medical Association, 307(6), 560-561.
  56. JT Walkup, AM Albano, J Piacentini, B Birmaher, SN Compton, JT Sherrill, GS Ginsburg, MA Rynn, J McCracken, B Waslick, S Iyengar, JS March and PC Kendall (2008). Cognitive behavioral therapy, sertraline, or a combination in childhood anxiety.. N Engl J Med, 359(26), 2753-2766.
  57. GS Ginsburg, SG Silva, RH Jacobs, S Tonev, RH Hoyle, JN Kingery, MA Reinecke, JF Curry and JS March (2009). Cognitive measures of adolescent depression: unique or unitary constructs?. J Clin Child Adolesc Psychol, 38(6), 790-802.
  58. JS March (2004). Cognitive-behavior therapy, sertraline, and their combination for children and adolescents with obsessive-compulsive disorder: The pediatric OCD treatment study (POTS) randomized controlled trial. Journal of the American Medical Association, 292(16), 1969-1976.
  59. P Barrett, L Healy-Farrell and JS March (2004). Cognitive-behavioral family treatment of childhood obsessive-compulsive disorder: A controlled trial. Journal of the American Academy of Child and Adolescent Psychiatry, 43(1), 46-62.
  60. TL Waters, PM Barrett and JS March (2001). Cognitive-behavioral family treatment of childhood obsessive-compulsive disorder: Preliminary findings. American Journal of Psychotherapy, 55(3), 372-387.
  61. SN Compton, JS March, D Brent, AM Albano, R Weersing and J Curry (2004). Cognitive-behavioral psychotherapy for anxiety and depressive disorders in children and adolescents: an evidence-based medicine review.. J Am Acad Child Adolesc Psychiatry, 43(8), 930-959.
  62. JS March (1995). Cognitive-behavioral psychotherapy for children and adolescents with OCD: a review and recommendations for treatment.. J Am Acad Child Adolesc Psychiatry, 34(1), 7-18.
  63. JS March, L Amaya-Jackson, MC Murray and A Schulte (1998). Cognitive-behavioral psychotherapy for children and adolescents with posttraumatic stress disorder after a single-incident stressor.. J Am Acad Child Adolesc Psychiatry, 37(6), 585-593.
  64. JS March, M Franklin, A Nelson and E Foa (2001). Cognitive-behavioral psychotherapy for pediatric obsessive-compulsive disorder.. J Clin Child Psychol, 30(1), 8-18.
  65. L Amaya-Jackson, V Reynolds, MC Murray, G McCarthy, A Nelson, MS Cherney, R Lee, E Foa and JS March (2003). Cognitive-Behavioral Treatment for Pediatric Posttraumatic Stress Disorder: Protocol and Application in School and Community Settings. Cognitive and Behavioral Practice, 10(3), 204-213.
  66. JS March (2002). Combining medication and psychosocial treatments: An evidence-based medicine approach. International Review of Psychiatry, 14(2), 155-163.
  67. JS March (2010). Commentary on 'Forum: use of antidepressants in children and adolescents'.. Curr Opin Psychiatry, 23(1), 63-65.
  68. S Pathak, CJ Kratochvil, GM Rogers, S Silva, B Vitiello, EB Weller and JS March (2005). Comparative efficacy of cognitive behavioral therapy, fluoxetine, and their combination in depressed adolescents: Initial lessons from the treatment for adolescents with depression study. Current Psychiatry Reports, 7(6), 429-434.
  69. LL Greenhill, B Vitiello, P Fisher, J Levine, M Davies, H Abikoff, AK Chrisman, S Chuang, RL Findling, J March, L Scahill, J Walkup and MA Riddle (2004). Comparison of increasingly detailed elicitation methods for the assessment of adverse events in pediatric psychopharmacology. Journal of the American Academy of Child and Adolescent Psychiatry, 43(12), 1488-1496.
  70. SP Hinshaw, JS March, H Abikoff, LE Arnold, DP Cantwell, CK Conners, GR Elliott, J Halperin, LL Greenhill, LT Hechtman and E al (1997). Comprehensive assessment of childhood attention-deficit hyperactivity disorder in the context of a multisite, multimodal clinical trial. Journal of Attention Disorders, 1(4), 217-234.
  71. Conners, C., Levin, E., Sparrow, E., Hinton, S., Erhardt, D., Meck, W., Rose, J., & March, J. (1996). Nicotine and attention in adult ADHD. Psychopharmacology Bulletin, 32, 67-73..
  72. Conners, C., March, J., Erhardt, D., & Butcher, T. (1996). Assessment of attention-deficit disorders. Journal of Psychoeducational Assessment, 32:186-205. Leonard H, March J, Allen A and Swedo S (in press): Serotonin reuptake inhibitors I: Pharmacology, Journal of the American Academy of Child and Adolescent Psychiatry.
  73. Conners, C., Wells, K., March, J., & Fiore, C. (1994). Methodological issues in the multimodal treatment of the disruptive behavior disorders. In L. Greenhill (Ed.), Psychiatric Clinics of North America: Disruptive Behavior Disorders (pp. 361-378). Philadelphia: Saunders..
  74. ME Domino, BJ Burns, SG Silva, CJ Kratochvil, B Vitiello, MA Reinecke, J Mario and JS March (2008). Cost-effectiveness of treatments for adolescent depression: results from TADS.. Am J Psychiatry, 165(5), 588-596.
  75. Davidson, J., & March, J. (in press). Traumatic stress disorders. In A. Tasman, J. Kay, & J. Lieberman (Eds.), Psychiatry . Philadelphia: Saunders. March, J., & Mulle, K. (in press). Cognitive-behavioral psychotherapy for obsessive-compulsive disorder. In E. Hibbs & P. Jensen (Eds.), Psychosocial Treatments for Child and Adolescent Disorders: Empirically Based Approaches . Washington: American Psychological Press..
  76. Davidson, J., Foa, E., Blank, A., Brett, E., Fairbank, J., Green, B., Herman, J., Keane, T., Kilpartick, D., March, J., McNally, R., Pitman, R., Resnick, H., & Rothbaum, B. (1996). Posttraumatic stress disorder. In T. Widiger, A. Frances, H. Pincus, M. Ross, M. First, & W. Davis (Eds.), DSM-IV Sourcebook (Vol. 2, pp. 577-605). Washington: APA Press..
  77. NE Caporino, DM Brodman, PC Kendall, AM Albano, J Sherrill, J Piacentini, D Sakolsky, B Birmaher, SN Compton, G Ginsburg and E al (2013). Defining treatment response and remission in child anxiety: Signal detection analysis using the pediatric anxiety rating scale. Journal of the American Academy of Child and Adolescent Psychiatry, 52(1), 57-67.
  78. NE Caporino, DM Brodman, PC Kendall, AM Albano, J Sherrill, J Piacentini, D Sakolsky, B Birmaher, SN Compton, G Ginsburg and E al (2012). Defining Treatment Response and Remission in Child Anxiety: Signal Detection Analysis Using the Pediatric Anxiety Rating Scale. Journal of the American Academy of Child and Adolescent Psychiatry.
  79. BS Molina, K Flory, SP Hinshaw, AR Greiner, LE Arnold, JM Swanson, L Hechtman, PS Jensen, B Vitiello, B Hoza, WE Pelham, GR Elliott, KC Wells, HB Abikoff, RD Gibbons, S Marcus, CK Conners, JN Epstein, LL Greenhill, JS March, JH Newcorn, JB Severe and T Wigal (2007). Delinquent behavior and emerging substance use in the MTA at 36 months: prevalence, course, and treatment effects.. J Am Acad Child Adolesc Psychiatry, 46(8), 1028-1040.
  80. DM Small, AD Simons, P Yovanoff, SG Silva, CC Lewis, JL Murakami and J March (2008). Depressed adolescents and comorbid psychiatric disorders: Are there differences in the presentation of depression?. Journal of Abnormal Child Psychology, 36(7), 1015-1028.
  81. AB Lewin, J Piacentini, CA Flessner, DW Woods, ME Franklin, NJ Keuthen, P Moore, M Khanna, JS March, DJ Stein and TLC-SAB (2009). Depression, anxiety, and functional impairment in children with trichotillomania.. Depress Anxiety, 26(6), 521-527.
  82. B Vitiello, DA Brent, LL Greenhill, G Emslie, K Wells, JT Walkup, B Stanley, O Bukstein, BD Kennard, S Compton, B Coffey, MF Cwik, K Posner, A Wagner, JS March, M Riddle, T Goldstein, J Curry, L Capasso, T Mayes, S Shen, SS Gugga, JB Turner, S Barnett and J Zelazny (2009). Depressive symptoms and clinical status during the Treatment of Adolescent Suicide Attempters (TASA) Study.. J Am Acad Child Adolesc Psychiatry, 48(10), 997-1004.
  83. LL Greenhill, B Vitiello, H Abikoff, J Levine, JS March, MA Riddle, L Capasso, TB Cooper, M Davies, P Fisher, RL Findling, J Fried, MJ Labellarte, JT McCracken, D McMahon, J Robinson, A Skrobala, L Scahill, E Varipatis, JT Walkup and JM Zito (2003). Developing methodologies for monitoring long-term safety of psychotropic medications in children: report on the NIMH conference, September 25, 2000.. J Am Acad Child Adolesc Psychiatry, 42(6), 651-655.
  84. EJ Costello, DS Pine, C Hammen, JS March, PM Plotsky, MM Weissman, J Biederman, HH Goldsmith, J Kaufman, PM Lewinsohn, M Hellander, K Hoagwood, DS Koretz, CA Nelson and JF Leckman (2002). Development and natural history of mood disorders.. Biol Psychiatry, 52(6), 529-542.
  85. EB Foa, M Coles, JD Huppert, RV Pasupuleti, ME Franklin and J March (2010). Development and Validation of a Child Version of the Obsessive Compulsive Inventory. Behavior Therapy, 41(1), 121-132.
  86. CU Correll, CJ Kratochvil and JS March (2011). Developments in pediatric psychopharmacology: focus on stimulants, antidepressants, and antipsychotics.. J Clin Psychiatry, 72(5), 655-670.
  87. M Villabø, M Gere, S Torgersen, JS March and PC Kendall (2012). Diagnostic efficiency of the child and parent versions of the Multidimensional Anxiety Scale for Children.. J Clin Child Adolesc Psychol, 41(1), 75-85.
  88. AD Simons, CN Marti, P Rohde, CC Lewis, J Curry and J March (2012). Does homework "matter" in cognitive behavioral therapy for adolescent depression?. Journal of Cognitive Psychotherapy, 26(4), 390-404.
  89. L Hechtman, J Etcovitch, R Platt, LE Arnold, HB Abikoff, JH Newcorn, B Hoza, SP Hinshaw, HC Kraemer and E al (2005). Does multimodal treatment of ADHD decrease other diagnoses?. Clinical Neuroscience Research, 5(5-6), 273-282.
  90. JS March (2006). Dr. March replies [2]. Journal of the American Academy of Child and Adolescent Psychiatry, 45(4), 383-384.
  91. JS March and JM Fegert (2012). Drug development in pediatric psychiatry: current status, future trends.. Child Adolesc Psychiatry Ment Health, 6, 7.
  92. RH Jacobs, SG Silva, MA Reinecke, JF Curry, GS Ginsburg, CJ Kratochvil and JS March (2009). Dysfunctional attitudes scale perfectionism: a predictor and partial mediator of acute treatment outcome among clinically depressed adolescents.. J Clin Child Adolesc Psychol, 38(6), 803-813.
  93. JF Leckman and JS March (2011). Editorial: Developmental neuroscience comes of age.. J Child Psychol Psychiatry, 52(4), 333-338.
  94. ED Levin, CK Conners, D Silva, W Canu and J March (2001). Effects of chronic nicotine and methylphenidate in adults with attention deficit/hyperactivity disorder.. Exp Clin Psychopharmacol, 9(1), 83-90.
  95. LE Arnold, M Elliott, L Sachs, HC Kraemer, HB Abikoff, CK Conners, LL Greenhill, SP Hinshaw, PS Jensen and E al (2003). Effects of ethnicity on treatment attendance, stimulant response/dose, and 14-month outcome in ADHD. Journal of Consulting and Clinical Psychology, 71(4), 713-727.
  96. JM Swanson, GR Elliott, LL Greenhill, T Wigal, LE Arnold, B Vitiello, L Hechtman, JN Epstein, WE Pelham, HB Abikoff, JH Newcorn, BS Molina, SP Hinshaw, KC Wells, B Hoza, PS Jensen, RD Gibbons, K Hur, A Stehli, M Davies, JS March, CK Conners, M Caron and ND Volkow (2007). Effects of stimulant medication on growth rates across 3 years in the MTA follow-up.. J Am Acad Child Adolesc Psychiatry, 46(8), 1015-1027.
  97. H Abikoff, LE Arnold, JH Newcorn, GR Elliott, L Hechtman, JB Severe, T Wigal, C Shapiro, DP Cantwell, CK Conners, LL Greenhill, SP Hinshaw, B Hoza, PS Jensen, HC Kraemer, JS March, WE Pelham, JM Swanson, B Vitiello and KC Wells (2002). Emergency/Adjunct services and attrition prevention for randomized clinical trials in children: the MTA manual-based solution.. J Am Acad Child Adolesc Psychiatry, 41(5), 498-504.
  98. PM Wehmeier, A Schacht, M Lehmann, RW Dittmann, SG Silva and JS March (2008). Emotional well-being in children and adolescents treated with atomoxetine for attention-deficit/hyperactivity disorder: findings from a patient, parent and physician perspective using items from the pediatric adverse event rating scale (PAERS).. Child Adolesc Psychiatry Ment Health, 2(1), 11.
  99. KC Herman, R Ostrander, JT Walkup, SG Silva and JS March (2007). Empirically derived subtypes of adolescent depression: latent profile analysis of co-occurring symptoms in the Treatment for Adolescents with Depression Study (TADS).. J Consult Clin Psychol, 75(5), 716-728.
  100. GL Stein, JF Curry, J Hersh, A Breland-Noble, J March, SG Silva, MA Reinecke and R Jacobs (2010). Ethnic differences among adolescents beginning treatment for depression.. Cultur Divers Ethnic Minor Psychol, 16(2), 152-158.
  101. RH Jacobs, JB Klein, MA Reinecke, SG Silva, S Tonev, A Breland-Noble, Z Martinovich, CJ Kratochvil, AJ Rezac, J Jones and JS March (2008). Ethnic Differences in Attributions and Treatment Expectancies for Adolescent Depression.. Int J Cogn Ther, 1(2), 163-178.
  102. LD Miller, A Laye-Gindhu, Y Liu, JS March, DS Thordarson and EJ Garland (2011). Evaluation of a preventive intervention for child anxiety in two randomized attention-control school trials.. Behav Res Ther, 49(5), 315-323.
  103. CA Flessner, J Sapyta, A Garcia, JB Freeman, ME Franklin, E Foa and J March (2011). Examining the psychometric properties of the family accommodation scale-parent-report (FAS-PR). Journal of Psychopathology and Behavioral Assessment, 33(1), 38-46.
  104. RH Jacobs, MA Reinecke, JK Gollan, N Jordan, SG Silva and JS March (2010). Extreme thinking in clinically depressed adolescents: Results from the Treatment for Adolescents with Depression Study (TADS). Behaviour Research and Therapy, 48(11), 1155-1159.
  105. JN Kingery, HO Kepley, GS Ginsburg, JT Walkup, SG Silva, RH Hoyle, MA Reinecke and JS March (2009). Factor structure and psychometric properties of the Children's Negative Cognitive Error Questionnaire with a clinically depressed adolescent sample.. J Clin Child Adolesc Psychol, 38(6), 768-780.
  106. DE May, MJ Hallin, CJ Kratochvil, SE Puumala, LS Smith, MA Reinecke, SG Silva, EB Weller, B Vitiello, A Breland-Noble and JS March (2007). Factors associated with recruitment and screening in the Treatment for Adolescents With Depression Study (TADS).. J Am Acad Child Adolesc Psychiatry, 46(7), 801-810.
  107. SP Hinshaw, EB Owens, KC Wells, HC Kraemer, HB Abikoff, LE Arnold, CK Conners, G Elliott, LL Greenhill and E al (2000). Family processes and treatment outcome in the MTA: Negative/ineffective parenting practices in relation to multimodal treatment. Journal of Abnormal Child Psychology, 28(6), 555-568.
  108. PS Jensen, SP Hinshaw, JM Swanson, LL Greenhill, CK Conners, LE Arnold, HB Abikoff, G Elliott, L Hechtman and E al (2001). Findings from the NIMH Multimodal Treatment Study of ADHD (MTA): Implications and applications for primary care providers. Journal of Developmental and Behavioral Pediatrics, 22(1), 60-73.
  109. MA Reinecke, JF Curry and JS March (2009). Findings from the Treatment for Adolescents with Depression Study (TADS): what have we learned? What do we need to know?. J Clin Child Adolesc Psychol, 38(6), 761-767.
  110. JS March (1992). Fluoxetine and fluvoxamine in PTSD [7]. American Journal of Psychiatry, 149(3), 413-.
  111. JS March, S Silva, S Petrycki, B Dubicka and P Ramchandani (2005). Fluoxetine plus cognitive behavioural therapy was most effective for adolescents with major depressive disorder. Evidence-Based Medicine, 10(2), 46-.
  112. J March, S Silva, S Petrycki, J Curry, K Wells, J Fairbank, B Burns, M Domino, S McNulty, B Vitiello, J Severe and Treatment for Adolescents With Depression Study (TADS) Team (2004). Fluoxetine, cognitive-behavioral therapy, and their combination for adolescents with depression: Treatment for Adolescents With Depression Study (TADS) randomized controlled trial.. JAMA, 292(7), 807-820.
  113. JS March, RL Moon and H Johnston (1990). Fluoxetine-TCA interaction. Journal of the American Academy of Child and Adolescent Psychiatry, 29(6), 985-986.
  114. DS Pine, JT Walkup, MJ Labellarte, MA Riddle, L Greenhill, R Klein, M Davies, M Sweeney, H Abikoff, S Hack and E al (2001). Fluvoxamine for the treatment of anxiety disorders in children and adolescents. New England Journal of Medicine, 344(17), 1279-1285.
  115. Foa E, March J: Behavioral psychotherapy for OCD. In (ed Greist J, Jefferson J): Diagnosis and treatment of OCD. Ciba-Geigy, 1993..
  116. B Vitiello, P Rohde, S Silva, K Wells, C Casat, B Waslick, A Simons, M Reinecke, E Weller, C Kratochvil and E al (2006). Functioning and quality of life in the Treatment for Adolescents with Depression Study (TADS). Journal of the American Academy of Child and Adolescent Psychiatry, 45(12), 1419-1426.
  117. Greenhill, L., Abikoff, H., Arnold, L., Cantwell, D., Conners, C., Wells, K., Elliott, G., Hechtman, L., Hinshaw, S., Hoza , B., Jensen, P., March, J., Newcorn, J., Pelham, W., Severe, J., Swanson, J., & Vitiello, B. (in press). Medication treatment strategies in the MTA study: relevance to clinicians and researchers. Journal of the American Academy of Child and Adolescent Psychiatry..
  118. Hooper, S. R., & March, J. S. (1995). Neuropsychology. In J. March (Ed.), Anxiety Disorders in Children and Adolescents (pp. 35-60). New York: Guilford Press..
  119. B Vitiello, MA Riddle, LL Greenhill, JS March, J Levine, RJ Schachar, H Abikoff, JM Zito, JT McCracken, JT Walkup, RL Findling, J Robinson, TB Cooper, M Davies, E Varipatis, MJ Labellarte, L Scahill and L Capasso (2003). How can we improve the assessment of safety in child and adolescent psychopharmacology?. J Am Acad Child Adolesc Psychiatry, 42(6), 634-641.
  120. JS March (2000). Imipramine plus cognitive behavioural therapy (CBT) was more effective than placebo plus CBT in adolescents with comorbid anxiety and depression who refused to attend school: Commentary. Evidence-Based Mental Health, 3(4), 107-.
  121. CC Lewis, AD Simons, LJ Nguyen, JL Murakami, MW Reid, SG Silva and JS March (2010). Impact of childhood trauma on treatment outcome in the Treatment for Adolescents with Depression Study (TADS).. J Am Acad Child Adolesc Psychiatry, 49(2), 132-140.
  122. LL Greenhill, JM Swanson, B Vitiello, M Davies, W Clevenger, M Wu, LE Arnold, HB Abikoff, OG Bukstein, CK Conners and E al (2001). Impairment and deportment responses to different methylphenidate doses in children with ADHD: The MTA titration trial. Journal of the American Academy of Child and Adolescent Psychiatry, 40(2), 180-187.
  123. JN Epstein, D Rabiner, DE Johnson, DP Fitzgerald, A Chrisman, A Erkanli, KK Sullivan, JS March, P Margolis, EC Norton and CK Conners (2007). Improving attention-deficit/hyperactivity disorder treatment outcomes through use of a collaborative consultation treatment service by community-based pediatricians: a cluster randomized trial.. Arch Pediatr Adolesc Med, 161(9), 835-840.
  124. LL Greenhill, B Vitiello, H Abikoff, J Levine, JS March, MA Riddle, L Capasso, T Cooper, M Davies, P Fisher and E al (2001). Improving the methods for evaluating the safety of psychotropic medications in children and adolescents. Current Therapeutic Research - Clinical and Experimental, 62(12), 873-884.
  125. JS March and DL Evans (2010). In Memoriam: Elizabeth Weller, M.D.. Biological Psychiatry, 67(7), e49.
  126. J March (2008). In Memory of Richard Todd. Biological Psychiatry, 64(10), e9.
  127. JS March (2008). In reply. Archives of General Psychiatry, 65(6), 723-724.
  128. L Giulino, P Gammon, K Sullivan, M Franklin, E Foa, R Maid and JS March (2002). Is parental report of upper respiratory infection at the onset of obsessive-compulsive disorder suggestive of pediatric autoimmune neuropsychiatric disorder associated with streptococcal infection?. J Child Adolesc Psychopharmacol, 12(2), 157-164.
  129. JH Krystal, CS Carter, D Geschwind, HK Manji, JS March, EJ Nestler, JK Zubieta, DS Charney, D Goldman, RE Gur, JA Lieberman, P Roy-Byrne, DR Rubinow, SA Anderson, S Barondes, KF Berman, J Blair, DL Braff, ES Brown, JR Calabrese, WA Carlezon, EH Cook, RJ Davidson, M Davis, R Desimone, WC Drevets, RS Duman, SM Essock, SV Faraone, R Freedman, KJ Friston, J Gelernter, B Geller, M Gill, E Gould, AA Grace, C Grillon, R Gueorguieva, AR Hariri, RB Innis, EG Jones, JE Kleinman, GF Koob, AD Krystal, E Leibenluft, DF Levinson, PR Levitt, DA Lewis, I Liberzon, BK Lipska, SR Marder, A Markou, GF Mason, CJ McDougle, BS McEwen, FJ McMahon, MJ Meaney, HY Meltzer, KR Merikangas, A Meyer-Lindenberg, K Mirnics, LM Monteggia, A Neumeister, CP O'Brien, MJ Owen, DS Pine, JL Rapoport, SL Rauch, TW Robbins, JF Rosenbaum, DR Rosenberg, CA Ross, AJ Rush, HA Sackeim, G Sanacora, AF Schatzberg, Y Shaham, LJ Siever, T Sunderland, LH Tecott, ME Thase, RD Todd, MM Weissman, R Yehuda, T Yoshikawa, EA Young and R McCandless (2008). It is time to take a stand for medical research and against terrorism targeting medical scientists.. Biol Psychiatry, 63(8), 725-727.
  130. Johnston H, Swift W, March J: High dose tricyclic therapy in children: A case report and commentary. Journal of Child and Adolescent Psychopharamcology 3: 115-125, 1993..
  131. Leonard, H., Swedo, S., March, J., & Rapoport, J. (1995). Obsessive-compulsive disorder. In G. Gabbard (Ed.), Treatments of Psychiatric Disorders (Vol. 1, pp. 301-314). Washington: American Psychiatric Press..
  132. Levin, E., Conners, C., Sparrow, E., Hinton, S., Erhardt, D., Meck, W., Rose, J., & March, J. (1996). Nicotine effects on adults with attention-deficit/hyperactivity disorder. Psychopharmacology, 123, 55-63..
  133. EJ Costello, A Angold, J March and J Fairbank (1998). Life events and post-traumatic stress: the development of a new measure for children and adolescents.. Psychol Med, 28(6), 1275-1288.
  134. EH Cook, KD Wagner, JS March, J Biederman, P Landau, R Wolkow and M Messig (2001). Long-term sertraline treatment of children and adolescents with obsessive-compulsive disorder. Journal of the American Academy of Child and Adolescent Psychiatry, 40(10), 1175-1181.
  135. JS March (2011). Looking to the future of research in pediatric anxiety disorders.. Depress Anxiety, 28(1), 88-98.
  136. Maletic, V., March, J., & Johnston, H. (1994). Child and Adolescent Psychopharmacology. In J. Jefferson & J. Greist (Eds.), Psychiatric Clinics of North America: Annual of Drug Therapy (Vol. 1, pp. 101-124). Philadelphia: Saunders..
  137. March J & Leonard H (in press): Obsessive-compulsive disorder in children and adolescents: a review of the past ten years, Journal of the American Academy of Child and Adolescent Psychiatry.
  138. March J & Mulle K (publication expected, Spring, 1996): A Guide to Cognitive- Behavioral Psychotherapy for Children and Adolescents with Obsessive- Compulsive Disorder, New York: Guilford Press.
  139. March J (ed) (1994): Anxiety Disorders in Children and Adolescents, New York: Guilford Press.
  140. March J, Amaya-Jackson L and Pyoos R (in press): Pediatric post-traumatic stress disorder, in Weiner J (ed): Textbook of Child and Adolescent Psychiatry. Washington,DC:American Psychiatric Press.
  141. March J, Amaya-Jackson L, Terry R, Costanzo P(in press): Post-traumatic stress symptomatology in children and adolescents after an industrial fire, J Amer Acad of Ch Adolesc Psychiatry.
  142. March J, Amaya-Jackson L: Post-traumatic stress disorder in children and adolescents, PTSD Research Quarterly, National Center for PTSD Research Quarterly, National Center for PTSD, White River Junction VT: Veterans Admnistration 4 (4): 1-7, 1993..
  143. March J, Parker J, Sullivan K, Stallings S, Conners CK (in press). The Multidimensional Anxiety Scale for Children (MASC): Factor structure, reliability and validity. J Amer Acad of Ch Adolesc Psychiatry.
  144. March, J. (1993). What Constitutes a Stressor? The \"Criterion A\" Issue. In J. Davidson & E. Foa (Eds.), Posttraumatic Stress Disorder: DSM-IV and Beyond (pp. 37-54). Wasington DC: American Psychiaric Press, Inc.
  145. March, J. (1995). Anxiety Disorders in Children and Adolescents. New York: Guilford Press March, J., Leonard, H. (in press), Obsessive-compulsive disorder: a review of the past ten years. Journal of the American Academy of Child and Adolescent Psychiatry.
  146. March, J. S. (1995). Cognitive-behavioral psychotherapy for children and adolescents with OCD: A review and recommendations for treatment. Journal of the American Academy of Child & Adolescent Psychiatry, 34(1), 7-18..
  147. March, J. S., Leonard, H. L., & Swedo, S. E. (1995). Obsessive-compulsive disorder. In J. March (Ed.), Anxiety Disorders in Children and Adolescents (pp. 251-275). New York: Guilford Press..
  148. March, J. S., Mulle, K., Stallings, P., Erhardt, D., & Conners, C. K. (1995). Organizing an anxiety disorders clinic. In J. March (Ed.), Anxiety Disorders in Children and Adolescents (pp. 420-435). New York: Guildord Press..
  149. March, J., Mulle, K. (1995), Manualized cognitive-behavioral psychotherapy for obsessive-compulsive disorder in childhood: a preliminary single case study. Journal of Anxiety Disorders. 9(2): 175-184.
  150. March, J., & Albano, A. (1996). Assessment of anxiety in children and adolescents. In M. Oldham (Ed.), Annual Review of Psychiatry (Vol. XVI, pp. 35-88). Washington: American Psychiatric Press..
  151. March, J., & Albano, A. (in press). Assessment of anxiety in children and adolescents. In T. Olendick (Ed.), Annual Review of Psychology. Washington: American Pychological Association Press..
  152. March, J., & Amaya-Jackson, L. (1994). Post-traumatic stress disorder in children and adolescents. PTSD Research Quarterly, 4(4), 1-7..
  153. March, J., & Mulle, K. (1994). How I Ran OCD Off My Land: A Guide to Cognitive-Behavioral Psychotherapy for Children and Adolescents with Obsessive-Compulsive Disorder, Currently distributed by the OC Foundation March, J. (1996). Manual for the Multidimensional Anxiety Scale for Children (MASC). Toronto: MultiHealth Systems..
  154. March, J., & Mulle, K. (1995). Manualized cognitive-behavioral psychotherapy for obsessive-compulsive disorder in childhood: a preliminary single case study. Journal of Anxiety Disorders, 9(2), 175-184..
  155. March, J., Amaya-Jackson, L., Costanzo, P., Terry, R. (in press), Post-traumatic stress in children and adolescents after an industrial fire. Journal of the American Academy of Child and Adolescent Psychiatry.
  156. March, J., Conners, C., Erhardt, D., & Johnston, H. (1995). Pharmacotherapy of Attention-Deficit Hyperactivity Disorder. In J. Jefferson & J. Greist (Eds.), Psychiatric Clinics of North America: Annual of Drug Therapy (Vol. 2, pp. 187-213). Philadelphia: Saunders..
  157. March, J., Leonard, H., Swedo, S. (1995). Pharmacotherapy of Obsessive-Compulsive Disorder. In M. Riddle (Ed.), Child Psychiatric Clinics of North America: Pharmacotherapy (pp. 217-236). New York: Saunders.
  158. March, J., Leonard, H., & Swedo, S. (1995). Neuropsychiatry of obsessive- compulsive disorder in children and adolescents. Comprehensive Therapy, 21(9), 507-512..
  159. March, J., Leonard, H., & Swedo, S. (1995). Pharmacotherapy of Obsessive- Compulsive Disorder. In M. Riddle (Ed.), Child Psychiatric Clinics of North America: Pharmacotherapy (pp. 217-236). New York: Saunders..
  160. March, J., Leonard, H., & Swedo, S. (in press). Neuropsychiatry of pediatric obsessive compulsive disorder. In E. Coffey & R. Brumback (Eds.), Textbook of Pediatric Neuropsychiatry . Washington: APA Press..
  161. March, J., Mulle, K., Herbel, B. (1994), Behavioral Psychotherapy for Children and Adolescents With Obsessive-Compulsive Disorder: An Open Trial of a New Protocol Driven Treatment Package. Journal of the American Academy of Child and Adolescent Psychiatry. 33(3): 333-341.
  162. March, J., Mulle, K., & Herbel, B. (1994). Behavioral Psychotherapy for Children and Adolescents With Obsessive-Compulsive Disorder: An Open Trial of a New Protocol Driven Treatment Package. Journal of the American Academy of Child and Adolescent Psychiatry, 33(3), 333-341..
  163. March, J., Parker, J., Sullivan, K., Stallings, P., Conners, C. (in press), The Multidimensional Anxiety Scale for Children (MASC): Factor structure, reliability and validity. J Am Acad Child Adolesc Psychiatry.
  164. March, J., Wells, K., & Conners, C. (1995). Attention-Deficit/Hyperactivity Disorder: Part I. Assessment and diagnosis. Journal of Practical Psychiatry and Behavioral Health, 2, 23-32..
  165. March, J., Wells, K., & Conners, C. (1996). Attention-Deficit/Hyperactivity Disorder: Part II. Treatment. Journal of practical psychiatry and behavioral health, 1, 219-228..
  166. A Przeworski, LA Zoellner, ME Franklin, A Garcia, J Freeman, JS March and EB Foa (2012). Maternal and child expressed emotion as predictors of treatment response in pediatric obsessive-compulsive disorder.. Child Psychiatry Hum Dev, 43(3), 337-353.
  167. LL Greenhill, HB Abikoff, LE Arnold, DP Cantwell, CK Conners, G Elliott, L Hechtman, SP Hinshaw, B Hoza, PS Jensen and E al (1996). Medication treatment strategies in the MTA study: Relevance to clinicians and researchers. Journal of the American Academy of Child and Adolescent Psychiatry, 35(10), 1304-1313.
  168. B Vitiello, JB Severe, LL Greenhill, LE Arnold, HB Abikoff, OG Bukstein, GR Elliott, L Hechtman, PS Jensen and E al (2001). Methylphenidate dosage for children with ADHD over time under controlled conditions: Lessons from the MTA. Journal of the American Academy of Child and Adolescent Psychiatry, 40(2), 188-196.
  169. CK Conners, JN Epstein, JS March, A Angold, KC Wells, J Klaric, JM Swanson, LE Arnold, HB Abikoff, GR Elliott, LL Greenhill, L Hechtman, SP Hinshaw, B Hoza, PS Jensen, HC Kraemer, JH Newcorn, WE Pelham, JB Severe, B Vitiello and T Wigal (2001). Multimodal treatment of ADHD in the MTA: an alternative outcome analysis.. J Am Acad Child Adolesc Psychiatry, 40(2), 159-167.
  170. LE Arnold, HB Abikoff, DP Cantwell, CK Conners, G Elliott, LL Greenhill, L Hechtman, SP Hinshaw, B Hoza and E al (1997). National Institute of Mental Health Collaborative Multimodal Treatment Study of Children With ADHD (the MTA): Design challenges and choices. Archives of General Psychiatry, 54(9), 865-870.
  171. JS March, HL Leonard and SE Swedo (1995). Neuropsychiatry of obsessive-compulsive disorder in children and adolescents.. Compr Ther, 21(9), 507-512.
  172. CK Conners, ED Levin, E Sparrow, SC Hinton, D Erhardt, WH Meck, JE Rose and J March (1996). Nicotine and attention in adult attention deficit hyperactivity disorder (ADHD).. Psychopharmacol Bull, 32(1), 67-73.
  173. ED Levin, CK Conners, E Sparrow, SC Hinton, D Erhardt, WH Meck, JE Rose and J March (1996). Nicotine effects on adults with attention-deficit/hyperactivity disorder.. Psychopharmacology (Berl), 123(1), 55-63.
  174. LE Arnold, HB Abikoff, DP Cantwell, CK Conners, GR Elliott, LL Greenhill, L Hechtman, SP Hinshaw, B Hoza, PS Jensen and E al (1997). NIMH collaborative multimodal treatment study of children with ADHD (MTA): Design, methodology, and protocol evolution. Journal of Attention Disorders, 2(3), 141-158.
  175. LE Arnold, S Chuang, M Davies, HB Abikoff, CK Conners, GR Elliott, LL Greenhill, L Hechtman, SP Hinshaw and E al (2004). Nine Months of Multicomponent Behavioral Treatment for ADHD and Effectiveness of MTA Fading Procedures. Journal of Abnormal Child Psychology, 32(1), 39-51.
  176. HB Abikoff, PS Jensen, LLE Arnold, B Hoza, L Hechtman, S Pollack, D Martin, J Alvir, JS March, S Hinshaw and E al (2002). Observed classroom behavior of children with ADHD: Relationship to gender and comorbidity. Journal of Abnormal Child Psychology, 30(4), 349-359.
  177. JS March, H Johnston and JH greist (1989). Obsessive-compulsive disorder. American Family Physician, 39(5), 175-182.
  178. JS March and HL Leonard (1996). Obsessive-compulsive disorder in children and adolescents: a review of the past 10 years.. J Am Acad Child Adolesc Psychiatry, 35(10), 1265-1273.
  179. J Curry, S Silva, P Rohde, G Ginsburg, B Kennard, C Kratochvil, A Simons, J Kirchner, D May, T Mayes, N Feeny, AM Albano, S Lavanier, M Reinecke, R Jacobs, E Becker-Weidman, E Weller, G Emslie, J Walkup, E Kastelic, B Burns, K Wells and J March (2012). Onset of alcohol or substance use disorders following treatment for adolescent depression. Journal of Consulting and Clinical Psychology, 80(2), 299-312.
  180. RA Shelby, TJ Somers, FJ Keefe, SG Silva, DC McKee, L She, SJ Waters, I Varia, YB Riordan, VM Knowles, M Blazing, JA Blumenthal and P Johnson (2009). Pain catastrophizing in patients with noncardiac chest pain: relationships with pain, anxiety, and disability.. Psychosom Med, 71(8), 861-868.
  181. MM Amaya, MA Reinecke, SG Silva and JS March (2011). Parental marital discord and treatment response in depressed adolescents. Journal of Abnormal Child Psychology, 39(3), 401-411.
  182. KC Wells, JN Epstein, SP Hinshaw, CK Conners, J Klaric, HB Abikoff, A Abramowitz, LE Arnold, G Elliott, LL Greenhill, L Hechtman, B Hoza, PS Jensen, JS March, W Pelham, L Pfiffner, J Severe, JM Swanson, B Vitiello and T Wigal (2000). Parenting and family stress treatment outcomes in attention deficit hyperactivity disorder (ADHD): an empirical analysis in the MTA study.. J Abnorm Child Psychol, 28(6), 543-553.
  183. JS March (2004). Pediatric Autoimmune Neuropsychiatric Disorders Associated With Streptococcal Infection (PANDAS): implications for clinical practice.. Arch Pediatr Adolesc Med, 158(9), 927-929.
  184. B Hoza, AC Gerdes, S Mrug, SP Hinshaw, WM Bukowski, JA Gold, LE Arnold, HB Abikoff, CK Conners, GR Elliott and E al (2005). Peer-assessed outcomes in the multimodal treatment study of children with attention deficit hyperactivity disorder. Journal of Clinical Child and Adolescent Psychology, 34(1), 74-86.
  185. Penn JV, March JS and Leonard, HL (in press). Obsessive-compulsive disorder in children and adolescents. In Dickstein L: Annual Review of Psychiatry: OCD Accross the Lifecycle, M. Pato (ed), 16: APA Press, Washington, DC.
  186. CJ Kratochvil, KD Wagner, G Emslie and J March (2005). Pharmacological management of treatment-resistant pediatric depression. Journal of the American Academy of Child and Adolescent Psychiatry, 44(2), 198-200.
  187. HL Leonard, J March, KC Rickler and AJ Allen (1997). Pharmacology of the selective serotonin reuptake inhibitors in children and adolescents. Journal of the American Academy of Child and Adolescent Psychiatry, 36(6), 725-736.
  188. SN Compton, CJ Kratochvil and JS March (2007). Pharmacotherapy for anxiety disorders in children and adolescents: an evidence-based medicine review.. Pediatr Ann, 36(9), 586-598.
  189. CJ Kratochvil, MJ Harrington, WJ Burke and JS March (2002). Pharmacotherapy of childhood anxiety disorders.. Current psychiatry reports, 4(4), 264-269.
  190. A Weintrob and JS March (2005). Placebo use [2] (multiple letters). Journal of the American Academy of Child and Adolescent Psychiatry, 44(7), 624-625.
  191. NC Feeny, EB Foa, KRH Treadwell and J March (2004). Posttraumatic stress disorder in youth: A critical review of the cognitive and behavioral treatment outcome literature. Professional Psychology: Research and Practice, 35(5), 466-476.
  192. JS March (1991). Posttraumatic stress in the emergency setting. Emergency Care Quarterly, 7(1), 74-81.
  193. JS March, L Amaya-Jackson, R Terry, P Costanzo (1997). Posttraumatic symptomatology in children and adolescents after an industrial fire.. Journal of the American Academy of Child and Adolescent Psychiatry, 36(8), 1080-8.
  194. RA King, H Leonard, J March, W Bernet, JE Dunne, M Adair, V Arnold, RS Benson, O Bukstein, J Kinlan and E al (1998). Practice parameters for the assessment and treatment of children and adolescents with obsessive-compulsive disorder. Journal of the American Academy of Child and Adolescent Psychiatry, 37(10 SUPPL.), 27S-45S.
  195. K Gersing, B Burchett, J March, T Ostbye and KR Krishnan (2007). Predicting antipsychotic use in children.. Psychopharmacol Bull, 40(3), 116-124.
  196. JS March and JF Curry (1998). Predicting the outcome of treatment.. J Abnorm Child Psychol, 26(1), 39-51.
  197. J Curry, P Rohde, A Simons, S Silva, B Vitiello, C Kratochvil, M Reinecke, N Feeny, K Wells, S Pathak, E Weller, D Rosenberg, B Kennard, M Robins, G Ginsburg and J March (2006). Predictors and moderators of acute outcome in the Treatment for Adolescents with Depression Study (TADS). Journal of the American Academy of Child and Adolescent Psychiatry, 45(12), 1427-1439.
  198. AM Garcia, JJ Sapyta, PS Moore, JB Freeman, ME Franklin, JS March and EB Foa (2010). Predictors and moderators of treatment outcome in the Pediatric Obsessive Compulsive Treatment Study (POTS I).. J Am Acad Child Adolesc Psychiatry, 49(10), 1024-1033.
  199. EG Becker-Weidman, MA Reinecke, RH Jacobs, Z Martinovich, SG Silva and JS March (2009). Predictors of hopelessness among clinically depressed youth. Behavioural and Cognitive Psychotherapy, 37(3), 267-291.
  200. CA Flessner, JB Freeman, J Sapyta, A Garcia, ME Franklin, JS March and E Foa (2011). Predictors of parental accommodation in pediatric obsessive-compulsive disorder: findings from the Pediatric Obsessive-Compulsive Disorder Treatment Study (POTS) trial.. J Am Acad Child Adolesc Psychiatry, 50(7), 716-725.
  201. CL Donnelly, L Amaya-Jackson and JS March (1999). Psychopharmacology of pediatric posttraumatic stress disorder. Journal of Child and Adolescent Psychopharmacology, 9(3), 203-220.
  202. KC Wells, WE Pelham, RA Kotkin, B Hoza, HB Abikoff, A Abramowitz, LE Arnold, DP Cantwell, CK Conners, R Del Carmen, G Elliott, LL Greenhill, L Hechtman, E Hibbs, SP Hinshaw, PS Jensen, JS March, JM Swanson and E Schiller (2000). Psychosocial treatment strategies in the MTA study: rationale, methods, and critical issues in design and implementation.. J Abnorm Child Psychol, 28(6), 483-505.
  203. JN Epstein, JS March, CK Conners and DL Jackson (1998). Racial differences on the Conners Teacher Rating Scale.. J Abnorm Child Psychol, 26(2), 109-118.
  204. J Curry, S Silva, P Rohde, G Ginsburg, C Kratochvil, A Simons, J Kirchner, D May, B Kennard, T Mayes, N Feeny, AM Albano, S Lavanier, M Reinecke, R Jacobs, E Becker-Weidman, E Weller, G Emslie, J Walkup, E Kastelic, B Burns, K Wells and J March (2011). Recovery and recurrence following treatment for adolescent major depression. Archives of General Psychiatry, 68(3), 263-270.
  205. ME Domino, EM Foster, B Vitiello, CJ Kratochvil, BJ Burns, SG Silva, MA Reinecke and JS March (2009). Relative cost-effectiveness of treatments for adolescent depression: 36-week results from the TADS randomized trial.. J Am Acad Child Adolesc Psychiatry, 48(7), 711-720.
  206. GS Ginsburg, PC Kendall, D Sakolsky, SN Compton, J Piacentini, AM Albano, JT Walkup, J Sherrill, KA Coffey, MA Rynn and E al (2011). Remission after acute treatment in children and adolescents with anxiety disorders: Findings from the CAMS. Journal of Consulting and Clinical Psychology, 79(6), 806-813.
  207. BD Kennard, SG Silva, S Tonev, P Rohde, JL Hughes, B Vitiello, CJ Kratochvil, JF Curry, GJ Emslie, M Reinecke and J March (2009). Remission and recovery in the treatment for adolescents with depression study (TADS): Acute and long-term outcomes. Journal of the American Academy of Child and Adolescent Psychiatry, 48(2), 186-195.
  208. B Kennard, S Silva, B Vitiello, J Curry, C Kratochvil, A Simons, J Hughes, N Feeny, E Weller, M Sweeney, M Reinecke, S Pathak, G Ginsburg, G Emslie and J March (2006). Remission and residual symptoms after short-term treatment in the Treatment of Adolescents with Depression Study (TADS). Journal of the American Academy of Child and Adolescent Psychiatry, 45(12), 1404-1411.
  209. B Vitiello, CJ Kratochvil, S Silva, J Curry, M Reinecke, S Pathak, B Waslick, CW Hughes, ED Prentice, DE May and JS March (2007). Research knowledge among the participants in the Treatment for Adolescents With Depression Study (TADS).. J Am Acad Child Adolesc Psychiatry, 46(12), 1642-1650.
  210. JM Swanson, LE Arnold, B Vitiello, HB Abikoff, KC Wells, WE Pelham, JS March, SP Hinshaw, B Hoza, JN Epstein and E al (2002). Response to commentary on the multimodal treatment study of ADHD (MTA): Mining the meaning of the MTA. Journal of Abnormal Child Psychology, 30(4), 327-332.
  211. CA Galanter, GA Carlson, PS Jensen, LL Greenhill, M Davies, W Li, SZ Chuang, GR Elliott, LE Arnold, JS March and E al (2003). Response to Methylphenidate in Children with Attention Deficit Hyperactivity Disorder and Manic Symptoms in the Multimodal Treatment Study of Children with Attention Deficit Hyperactivity Disorder Titration Trial. Journal of Child and Adolescent Psychopharmacology, 13(2), 123-136.
  212. LL Greenhill, B Vitiello, MA Riddle, P Fisher, E Shockey, JS March, J Levine, J Fried, H Abikoff, JM Zito, JT McCracken, RL Findling, J Robinson, TB Cooper, M Davies, E Varipatis, MJ Labellarte, L Scahill, JT Walkup, L Capasso and J Rosengarten (2003). Review of safety assessment methods used in pediatric psychopharmacology.. J Am Acad Child Adolesc Psychiatry, 42(6), 627-633.
  213. JS March (2005). Review: a pooled long term persistence rate of 40% for childhood OCD is lower than previously expected.. Evid Based Ment Health, 8(1), 6.
  214. JS March (2004). Review: clomipramine is more effective than SSRIs for paediatric obsessive compulsive disorder.. Evid Based Ment Health, 7(2), 50.
  215. Sahoo T, Goenaga-Diaz E, Serebreiiskii IG, Thomas JW, Kotova E, Cuellar JG, Peloquin JM, Golemis E, Beitinjaneh F, Green ED, Johnson EW, and Marchuk DA. Computational and experimental analyses reveal previously undetected coding exons of the KRIT1 (CCM1) gene. Genomics, 71:123-126, 2001..
  216. JM Swanson, SP Hinshaw, LE Arnold, RD Gibbons, S Marcus, K Hur, PS Jensen, B Vitiello, HB Abikoff, LL Greenhill, L Hechtman, WE Pelham, KC Wells, CK Conners, JS March, GR Elliott, JN Epstein, K Hoagwood, B Hoza, BS Molina, JH Newcorn, JB Severe and T Wigal (2007). Secondary evaluations of MTA 36-month outcomes: propensity score and growth mixture model analyses.. J Am Acad Child Adolesc Psychiatry, 46(8), 1003-1014.
  217. CJ Kratochvil, B Vitiello, J Walkup, G Emslie, BD Waslick, EB Weller, WJ Burke and JS March (2006). Selective serotonin reuptake inhibitors in pediatric depression: Is the balance between benefits and risks favorable?. Journal of Child and Adolescent Psychopharmacology, 16(1-2), 11-24.
  218. H Abikoff, J McGough, B Vitiello, J McCracken, M Davies, J Walkup, M Riddle, M Oatis, L Greenhill, A Skrobala and E al (2005). Sequential pharmacotherapy for children with comorbid attention-deficit/ hyperactivity and anxiety disorders. Journal of the American Academy of Child and Adolescent Psychiatry, 44(5), 418-427.
  219. JS March, LD Gutzman, JW Jefferson and JH Greist (1989). Serotonin and treatment in obsessive-complusive disorder. Psychiatric Developments, 7(1), 1-18.
  220. JS March, J Biederman, R Wolkow, A Safferman, J Mardekian, EH Cook, NR Cutler, R Dominguez, J Ferguson, B Muller, R Riesenberg, M Rosenthal, FR Sallee, KD Wagner and H Steiner (1998). Sertraline in children and adolescents with obsessive-compulsive disorder: a multicenter randomized controlled trial.. JAMA, 280(20), 1752-1756.
  221. SN Compton, PJ Grant, AK Chrisman, PJ Gammon, VL Brown and JS March (2001). Sertraline in children and adolescents with social anxiety disorder: an open trial.. J Am Acad Child Adolesc Psychiatry, 40(5), 564-571.
  222. KD Wagner, P Ambrosini, M Rynn and J March (2004). Sertraline reduced the severity of patients' depressive symptoms in major depressive disorder. Evidence-Based Medicine, 9(2), 46-.
  223. ME Domino, BJ Burns, J Mario, MA Reinecke, B Vitiello, EB Weller, CJ Kratochvil, DE May, NC Feeny, M Robins, MJ Hallin, SG Silva and JS March (2009). Service use and costs of care for depressed adolescents: who uses and who pays?. J Clin Child Adolesc Psychol, 38(6), 826-836.
  224. JS March (1990). Sleep disturbance in PTSD. American Journal of Psychiatry, 147(12), 1697-.
  225. SN Compton, AH Nelson and JS March (2000). Social phobia and separation anxiety symptoms in community and clinical samples of children and adolescents.. J Am Acad Child Adolesc Psychiatry, 39(8), 1040-1046.
  226. EG Becker-Weidman, RH Jacobs, MA Reinecke, SG Silva and JS March (2010). Social problem-solving among adolescents treated for depression. Behaviour Research and Therapy, 48(1), 11-18.
  227. R Rieppi, LL Greenhill, RE Ford, S Chuang, M Wu, M Davies, HB Abikoff, LE Arnold, CK Conners, GR Elliott and E al (2002). Socioeconomic Status as a Moderator of ADHD Treatment Outcomes. Journal of the American Academy of Child and Adolescent Psychiatry, 41(3), 269-277.
  228. SW Heimann and JS March (1996). SSRI-induced mania [3]. Journal of the American Academy of Child and Adolescent Psychiatry, 35(1), 4-.
  229. Stallings, P., & March, J. (1995). Assessment of Anxiety in Children and Adolescents. In J. March (Ed.), Anxiety Disorders in Children and Adolescents (pp. 125-147). New York: Guilford..
  230. J Freeman, J Sapyta, A Garcia, D Fitzgerald, M Khanna, M Choate-Summers, P Moore, A Chrisman, N Haff, A Naeem, J March and M Franklin (2011). Still Struggling: Characteristics of youth with OCD who are partial responders to medication treatment. Child Psychiatry and Human Development, 42(4), 424-441.
  231. B Vitiello, SG Silva, P Rohde, CJ Kratochvil, BD Kennard, MA Reinecke, TL Mayes, K Posner, DE May and JS March (2009). Suicidal events in the Treatment for Adolescents With Depression Study (TADS).. J Clin Psychiatry, 70(5), 741-747.
  232. RA King, H Leonard, J March, W Bernet, JE Dunne, M Adair, V Arnold, RS Benson, O Bukstein, J Kinlan and E al (1998). Summary of the practice parameters for the assessment and treatment of children and adolescents with obsessive-compulsive disorder. Journal of the American Academy of Child and Adolescent Psychiatry, 37(10), 1110-1116.
  233. AE Layne, GA Bernstein and JS March (2006). Teacher awareness of anxiety symptoms in children. Child Psychiatry and Human Development, 36(4), 383-392.
  234. JS March and K Sullivan (1999). Test-retest reliability of the Multidimensional Anxiety Scale for Children.. J Anxiety Disord, 13(4), 349-358.
  235. JS March, SG Silva, S Compton, M Shapiro, R Califf and R Krishnan (2005). The case for practical clinical trials in psychiatry.. Am J Psychiatry, 162(5), 836-846.
  236. JS March, SG Silva, S Compton, G Anthony, J DeVeaugh-Geiss, R Califf and R Krishnan (2004). The Child and Adolescent Psychiatry Trials Network (CAPTN).. J Am Acad Child Adolesc Psychiatry, 43(5), 515-518.
  237. M Shapiro, SG Silva, S Compton, A Chrisman, J DeVeaugh-Geiss, A Breland-Noble, D Kondo, J Kirchner and JS March (2009). The child and adolescent psychiatry trials network (CAPTN): infrastructure development and lessons learned.. Child Adolesc Psychiatry Ment Health, 3(1), 12.
  238. AK Langley, A Falk, T Peris, JF Wiley, PC Kendall, G Ginsburg, B Birmaher, J March, AM Albano and J Piacentini (2013). The Child Anxiety Impact Scale: Examining Parent- and Child-Reported Impairment in Child Anxiety Disorders. Journal of Clinical Child and Adolescent Psychology.
  239. GM Rogers, JH Park, MJ Essex, MH Klein, SG Silva, RH Hoyle, JF Curry, NC Feeny, B Kennard, CJ Kratochvil, S Pathak, MA Reinecke, DR Rosenberg, EB Weller and JS March (2009). The dysfunctional attitudes scale: psychometric properties in depressed adolescents.. J Clin Child Adolesc Psychol, 38(6), 781-789.
  240. JN Epstein, NA Goldberg, CK Conners and JS March (1997). The effects of anxiety on continuous performance test functioning in an ADHD clinic sample. Journal of Attention Disorders, 2(1), 45-52.
  241. AT Derivan, BL Leventhal, J March, M Wolraich and JM Zito (2004). The ethical use of placebo in clinical trials involving children. Journal of Child and Adolescent Psychopharmacology, 14(2), 169-174.
  242. BS Vaughan, JS March and CJ Kratochvil (2012). The evidence-based pharmacological treatment of paediatric ADHD. International Journal of Neuropsychopharmacology, 15(1), 27-39.
  243. JS March (2009). The future of psychotherapy for mentally ill children and adolescents.. J Child Psychol Psychiatry, 50(1-2), 170-179.
  244. CA Flessner, A Allgair, A Garcia, J Freeman, J Sapyta, ME Franklin, E Foa and J March (2010). The impact of neuropsychological functioning on treatment outcome in pediatric obsessive-compulsive disorder. Depression and Anxiety, 27(4), 365-371.
  245. JS March, C Conners, G Arnold, J Epstein, J Parker, S Hinshaw, H Abikoff, B Molina, K Wells, J Newcorn and E al (1999). The Multidimensional Anxiety Scale for Children (MASC): Confirmatory factor analysis in a pediatric ADHD sample. Journal of Attention Disorders, 3(2), 85-89.
  246. JS March, JD Parker, K Sullivan, P Stallings, CK Conners (1997). The Multidimensional Anxiety Scale for Children (MASC): factor structure, reliability, and validity.. Journal of the American Academy of Child and Adolescent Psychiatry, 36(4), 554-65.
  247. JS March (1990). The nosology of Posttraumatic Stress Disorder. Journal of Anxiety Disorders, 4(1), 61-82.
  248. J Freeman, A Garcia, K Benito, C Conelea, J Sapyta, M Khanna, J March and M Franklin (2012). The pediatric obsessive compulsive disorder treatment study for young children (POTS Jr): Developmental considerations in the rationale, design, and methods. Journal of Obsessive-Compulsive and Related Disorders, 1(4), 294-300.
  249. JB Freeman, ML Choate-Summers, AM Garcia, PS Moore, JJ Sapyta, MS Khanna, JS March, EB Foa and ME Franklin (2009). The Pediatric Obsessive-Compulsive Disorder Treatment Study II: rationale, design and methods.. Child Adolesc Psychiatry Ment Health, 3(1), 4.
  250. M Franklin, E Foa and JS March (2003). The pediatric obsessive-compulsive disorder treatment study: rationale, design, and methods.. J Child Adolesc Psychopharmacol, 13 Suppl 1, S39-S51.
  251. JS March (2011). The preschool ADHD Treatment Study (PATS) as the culmination of twenty years of clinical trials in pediatric psychopharmacology.. J Am Acad Child Adolesc Psychiatry, 50(5), 427-430.
  252. CC Lewis, AD Simons, SG Silva, P Rohde, DM Small, JL Murakami, RR High and JS March (2009). The role of readiness to change in response to treatment of adolescent depression.. J Consult Clin Psychol, 77(3), 422-428.
  253. CJ Kratochvil, LL Greenhill, JS March, WJ Burke and BS Vaughan (2004). The role of stimulants in the treatment of preschool children with attention-deficit hyperactivity disorder.. CNS Drugs, 18(14), 957-966.
  254. J March, S Silva, S Petrycki, J Curry, K Wells, J Fairbank, B Burns, M Domino, S McNulty, B Vitiello, J Severe, C Casat, J Kolker, K Riedal, M Goldman, N Feeny, R Findling, S Stull, N McNamara, E Weller, M Robins, R Weller, N Jessani, B Waslick, M Sweeney, R Kandel, D Schoenholz, J Walkup, G Ginsburg, E Kastelic, H Koo, C Kratochvil, D May, R LaGrone, M Harrington, AM Albano, G Hirsch, T Knibbs, E Capili, M Reinecke, B Leventhal, C Nageotte, G Rogers, S Pathak, J Wells, S Arszman, A Danielyan, A Simons, P Rohde, J Grimm, L Nguyen, G Emslie, B Kennard, C Hughes, M Ruberu, D Rosenberg, N Benazon, M Butkus, M Bartoi, G Clarke, D Brent and G Koch (2005). The Treatment for Adolescents with Depression Study (TADS): Demographic and clinical characteristics. Journal of the American Academy of Child and Adolescent Psychiatry, 44(1), 28-40.
  255. JS March, S Silva, S Petrycki, J Curry, K Wells, J Fairbank, B Burns, M Domino, S McNulty, B Vitiello and J Severe (2007). The Treatment for Adolescents With Depression Study (TADS): long-term effectiveness and safety outcomes.. Arch Gen Psychiatry, 64(10), 1132-1143.
  256. J March, S Silva and B Vitiello (2006). The Treatment for Adolescents with Depression Study (TADS): Methods and message at 12 weeks. Journal of the American Academy of Child and Adolescent Psychiatry, 45(12), 1393-1403.
  257. Treatment for Adolescents With Depression Study (TADS) Team, J March, S Silva, J Curry, K Wells, J Fairbank, B Burns, M Domino, B Vitiello, J Severe, K Riedal, M Goldman, N Feeny, R Findling, S Stull, S Baab, EB Weller, M Robbins, RA Weller, N Jessani, B Waslick, M Sweeney, R Dublin, J Walkup, G Ginsburg, E Kastelic, H Koo, C Kratochvil, D May, R LaGrone, B Vaughan, AM Albano, GS Hirsch, E Podniesinki, A Chu, M Reincecke, B Leventhal, G Rogers, R Jacobs, S Pathak, J Wells, SA Lavanier, A Danielyan, P Rohde, A Simons, J Grimm, S Frank, G Emslie, B Kennard, C Hughes, TL Mayes, D Rosenberg, N Benazon, M Butkus and M Bartoi (2009). The Treatment for Adolescents With Depression Study (TADS): outcomes over 1 year of naturalistic follow-up.. Am J Psychiatry, 166(10), 1141-1149.
  258. DA Brent, LL Greenhill, S Compton, G Emslie, K Wells, JT Walkup, B Vitiello, O Bukstein, B Stanley, K Posner, BD Kennard, MF Cwik, A Wagner, B Coffey, JS March, M Riddle, T Goldstein, J Curry, S Barnett, L Capasso, J Zelazny, J Hughes, S Shen, SS Gugga and JB Turner (2009). The Treatment of Adolescent Suicide Attempters study (TASA): predictors of suicidal events in an open treatment trial.. J Am Acad Child Adolesc Psychiatry, 48(10), 987-996.
  259. JL Podell, PC Kendall, EA Gosch, SN Compton, JS March, A-M Albano, MA Rynn, JT Walkup, JT Sherrill, GS Ginsburg, CP Keeton, B Birmaher and JC Piacentini (2013). Therapist Factors and Outcomes in CBT for Anxiety in Youth. PROFESSIONAL PSYCHOLOGY-RESEARCH AND PRACTICE, 44(2), 89-98.
  260. JS March, ME Franklin, H Leonard, A Garcia, P Moore, J Freeman and E Foa (2007). Tics moderate treatment outcome with sertraline but not cognitive-behavior therapy in pediatric obsessive-compulsive disorder.. Biol Psychiatry, 61(3), 344-347.
  261. ED Levin, CK Conners, D Silva, SC Hinton, WH Meck, J March and JE Rose (1998). Transdermal nicotine effects on attention.. Psychopharmacology (Berl), 140(2), 135-141.
  262. RH Jacobs, EG Becker-Weidman, MA Reinecke, N Jordan, SG Silva, P Rohde and JS March (2010). Treating depression and oppositional behavior in adolescents. Journal of Clinical Child and Adolescent Psychology, 39(4), 559-567.
  263. JS March, BJ Klee and CM Kremer (2006). Treatment benefit and the risk of suicidality in multicenter, randomized, controlled trials of sertraline in children and adolescents.. J Child Adolesc Psychopharmacol, 16(1-2), 91-102.
  264. J March, S Silva, S Petrycki, J Curry, K Wells, J Fairbank, B Burns, M Domino, B Vitiello, J Severe, C Casat, J Kolker, N Feeny, R Findling, S Stull, S Baab, B Waslick, M Sweeney, L Kentgen, R Kandel, J Walkup, G Ginsburg, E Kastelik, H Koo, C Kratochvil, D May, R LaGrone, M Harrington, AM Albano, G Hirsch, T Knibbs, E Capili, M Reinecke, B Leventhal, C Nageotte, G Rogers, S Pathak, F Sallee, E Cottingham, J Wells, P Rohde, A Simons, J Grimm, K Hadjiyannakis, E Weller, M Robins, R Weller, N Jessani, G Emslie, B Kennard, C Hughes, M Ruberu, N Benazon, D Rosenberg, M Butkus, M Bartoi, G Clarke, D Brent and G Koch (2003). Treatment for Adolescents with Depression Study (TADS): Rationale, design, and methods. Journal of the American Academy of Child and Adolescent Psychiatry, 42(5), 531-542.
  265. G Emslie, C Kratochvil, B Vitiello, S Silva, T Mayes, S McNulty, E Weller, B Waslick, C Casat, J Walkup and E al (2006). Treatment for Adolescents with Depression Study (TADS): Safety results. Journal of the American Academy of Child and Adolescent Psychiatry, 45(12), 1440-1455.
  266. J Walkup, H Abikoff, S Hack, B Klee, RL Bergman, D Lynn, J McCracken, J March, P Gammon, J Robinson and E al (2002). Treatment of pediatric anxiety disorders: An open-label extension of the research units on pediatric psychopharmacology anxiety study. Journal of Child and Adolescent Psychopharmacology, 12(3), 175-188.
  267. ME Franklin, DF Tolin, JS March and EB Foa (2001). Treatment of pediatric obsessive-compulsive disorder: A case example of intensive cognitive-behavioral therapy involving exposure and ritual prevention. Cognitive and Behavioral Practice, 8(4), 297-304.
  268. CJ Kratochvil, DE May, SG Silva, V Madaan, SE Puumala, JF Curry, J Walkup, H Kepley, B Vitiello and JS March (2009). Treatment response in depressed adolescents with and without co-morbid attention-deficit/hyperactivity disorder in the Treatment for Adolescents with Depression Study.. J Child Adolesc Psychopharmacol, 19(5), 519-527.
  269. KC Wells, TC Chi, SP Hinshaw, JN Epstein, L Pfiffner, M Nebel-Schwalm, EB Owens, LE Arnold, HB Abikoff, CK Conners, GR Elliott, LL Greenhill, L Hechtman, B Hoza, PS Jensen, J March, JH Newcorn, WE Pelham, JB Severe, J Swanson, B Vitiello and T Wigal (2006). Treatment-related changes in objectively measured parenting behaviors in the multimodal treatment study of children with attention-deficit/hyperactivity disorder.. J Consult Clin Psychol, 74(4), 649-657.
  270. JS March, A Chrisman, A Breland-Noble, K Clouse, R D'Alli, H Egger, P Gammon, M Gazzola, A Lin, C Mauro, A Rana, H Ravi, M Srirama, H Su, G Thrall, P van de Velde and Duke Pediatric Psychiatry EBM Seminar Team (2005). Using and teaching evidence-based medicine: the Duke University child and adolescent psychiatry model.. Child Adolesc Psychiatr Clin N Am, 14(2), 273-ix.
  271. J March, HC Kraemer, M Trivedi, J Csernansky, J Davis, TA Ketter and ID Glick (2010). What have we learned about trial design from NIMH-funded pragmatic trials. Neuropsychopharmacology, 35(13), 2491-2501.
  272. EB Owens, SP Hinshaw, LE Arnold, DP Cantwell, G Elliott, L Hechtman, PS Jensen, JH Newcorn, JB Severe, B Vitiello and E al (2003). Which treatment for whom for ADHD? Moderators of treatment response in the MTA. Journal of Consulting and Clinical Psychology, 71(3), 540-552.